(Q45282181)

English

Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

author name string

Steven Shoptaw

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Donnie W Watson

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Chris Reiber

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Richard A Rawson

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Margaret A Montgomery

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Maria D Majewska

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Walter Ling

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

100 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

78-90

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

Effects of long-term ergoloid mesylates ('Hydergine') administration in healthy pensioners: 5-year results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

Two types of neurone in the rat ventral tegmental area and their synaptic inputs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: a 6-month double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

Overview of clinical trials of hydergine in dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2005.00991.X

21 January 2018

Identifiers

10.1111/J.1360-0443.2005.00991.X

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45282181&oldid=1768952385"